VEGF and CD31 Association in Pituitary Adenomas

作者: Carolina Cristina , María Inés Perez-Millan , Guillermina Luque , Raúl Ariel Dulce , Gustavo Sevlever

DOI: 10.1007/S12022-010-9119-6

关键词:

摘要: Pituitary tumors are usually less vascularized than the normal pituitary, and role of angiogenesis in these adenomas is contentious. Appraisal microvascular density expression potent angiogenic vascular endothelial growth factor (VEGF) by immunohistochemistry has yielded controversial results, as a broad spectrum immunostaining can be found. We determined protein VEGF CD31, an marker, series 56 surgically removed pituitary using Western blot assay. Prolactinomas had higher compared to nonfunctioning or ACTH- GH-secreting adenomas, while CD31 was similar different adenoma histotypes. were not affected sex, age, years evolution, proliferation rate (Ki67 PCNA) for all types. Only concentration increased significantly with age. There positive correlation between when histotypes considered, prolactinomas evaluated separately. The association suggests participation development, epithelial cell directly related expression, other factors, such primary genetic alterations may involved.

参考文章(40)
Ricardo V. Lloyd, Sergio Vidal, Eva Horvath, Kalman Kovacs, Bernd Scheithauer, Angiogenesis in normal and neoplastic pituitary tissues. Microscopy Research and Technique. ,vol. 60, pp. 244- 250 ,(2003) , 10.1002/JEMT.10263
A. K. Wong, M. Alfert, D. H. Castrillon, Q. Shen, J. Holash, G. D. Yancopoulos, L. Chin, Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 7481- 7486 ,(2001) , 10.1073/PNAS.121192298
Young Nyun Park, Chanil Park, Kyung Moo Yang, Young-Bae Kim, Increased Expression of Vascular Endothelial Growth Factor and Angiogenesis in the Early Stage of Multistep Hepatocarcinogenesis Archives of Pathology & Laboratory Medicine. ,vol. 124, pp. 1061- 1065 ,(2000) , 10.1043/0003-9985(2000)124<1061:IEOVEG>2.0.CO;2
Joel Schechter, Ultrastructural changes in the capillary bed of human pituitary tumors. American Journal of Pathology. ,vol. 67, pp. 109- 126 ,(1972)
Hiroyuki Yoshioka, Kazuhiko Sugiyama, Kazunori Arita, Fumiyuki Yamasaki, Yukari Kanou, Kuniki Eguchi, Atsushi Tominaga, Kaoru Kurisu, Seiji Hama, Relationship between Intratumoral Hemorrhage and Overexpression of Vascular Endothelial Growth Factor (VEGF) in Pituitary Adenoma Hiroshima journal of medical sciences. ,vol. 53, pp. 23- 27 ,(2004)
Carolina Cristina, Isabel García-Tornadú, Graciela Díaz-Torga, Marcelo Rubinstein, Malcolm J. Low, Damasia Becú-Villalobos, Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. Frontiers of Hormone Research. ,vol. 35, pp. 50- 63 ,(2006) , 10.1159/000094308
Franklin Joseph, Navid Younis, Geoffery Haydon, David H Adams, Siann Wynne, Martin B Gillet, Yasmine M Maurice, Mark E Lipton, David Berstock, Ian R Jones, Peliosis of the spleen with massive recurrent haemorrhagic ascites, despite splenectomy, and associated with elevated levels of vascular endothelial growth factor. European Journal of Gastroenterology & Hepatology. ,vol. 16, pp. 1401- 1406 ,(2004) , 10.1097/00042737-200412000-00027
María Niveiro, F. Ignacio Aranda, Gloria Peiró, Cristina Alenda, Antonio Picó, Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Human Pathology. ,vol. 36, pp. 1090- 1095 ,(2005) , 10.1016/J.HUMPATH.2005.07.015
Jacques E. Nör, Joan Christensen, David J. Mooney, Peter J. Polverini, Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression American Journal of Pathology. ,vol. 154, pp. 375- 384 ,(1999) , 10.1016/S0002-9440(10)65284-4